scispace - formally typeset
M

Miriam de Nadal

Researcher at Autonomous University of Barcelona

Publications -  35
Citations -  437

Miriam de Nadal is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 24 publications receiving 240 citations. Previous affiliations of Miriam de Nadal include Universidad Tecnológica de Bolívar & Hebron University.

Papers
More filters
letters-and-commentsDOI

Tranexamic Acid in Patients Undergoing Noncardiac Surgery.

TL;DR: Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo, and the between-group difference in the composite cardiovascular outcome was small, the noninferiority of tranxamic acid was not established.
Book ChapterDOI

Cerebral hemodynamic changes during sustained hypocapnia in severe head injury: can hyperventilation cause cerebral ischemia?

TL;DR: Monitoring of AVDO2 or other haemometabolic variables should be mandatory when sustained HV is used in the management of head injury patients, as it showed that HV was very effective in lowering ICP.
Journal ArticleDOI

Bilateral suprazygomatic maxillary nerve blocks vs. infraorbital and palatine nerve blocks in cleft lip and palate repair: A double-blind, randomised study.

TL;DR: Bilateral suprazygomatic maxillary nerve block is an effective and safe alternative to the traditional peripheral nerve blocks for cleft lip and cleft palate surgery, in a mixed paediatric and adult population.
Journal ArticleDOI

Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE).

TL;DR: The Management of Myocardial Injury After Noncardiac Surgery (MANAGE) trial is the first randomized controlled trial to evaluate a potential treatment of patients who suffered MINS and presents the rationale and design of the trial and baseline characteristics of enrolled patients.